2j4z: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The optimization of a series of 5-phenylacetyl | The optimization of a series of 5-phenylacetyl 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives toward the inhibition of Aurora kinases led to the identification of compound 9d. This is a potent inhibitor of Aurora kinases that also shows low nanomolar potency against additional anticancer kinase targets. Based on its high antiproliferative activity on different cancer cell lines, favorable chemico-physical and pharmacokinetic properties, and high efficacy in in vivo tumor models, compound 9d was ultimately selected for further development. | ||
==Disease== | ==Disease== | ||
Line 18: | Line 18: | ||
[[Category: Berta, D.]] | [[Category: Berta, D.]] | ||
[[Category: Bindi, S.]] | [[Category: Bindi, S.]] | ||
[[Category: Cameron, A | [[Category: Cameron, A D.]] | ||
[[Category: Fancelli, D.]] | [[Category: Fancelli, D.]] | ||
[[Category: Forte, B.]] | [[Category: Forte, B.]] | ||
Line 40: | Line 40: | ||
[[Category: transferase]] | [[Category: transferase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:59:13 2008'' |